TARA COYLE: Open Payments
NPI 1720670342 · SHELBYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,766 in 96 payments from 22 companies in 2025. Trend: 2023 $2,178 · 2024 $1,977 · 2025 $1,766
Food & beverage: $1,733Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $286 |
| Novo Nordisk Inc | 14 | $216 |
| Amgen Inc. | 9 | $208 |
| AstraZeneca Pharmaceuticals LP | 4 | $158 |
| Bausch Health US, LLC | 10 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $109 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Lilly USA, LLC | 4 | $71 |
| Esperion Therapeutics, Inc. | 4 | $63 |
Products named: UBRELVY, APLENZIN, REPATHA, BREZTRI, Kerendia, LEQVIO, Wegovy, CAPLYTA.
Industry payments across KY — which companies pay providers there.
